These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2284218)

  • 1. Clinical pharmacokinetic studies with lornoxicam.
    Turner P; Johnston A
    Postgrad Med J; 1990; 66 Suppl 4():S28-9. PubMed ID: 2284218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of lornoxicam in man.
    Hitzenberger G; Radhofer-Welte S; Takacs F; Rosenow D
    Postgrad Med J; 1990; 66 Suppl 4():S22-7. PubMed ID: 2284217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of lornoxicam. A short half-life oxicam.
    Skjodt NM; Davies NM
    Clin Pharmacokinet; 1998 Jun; 34(6):421-8. PubMed ID: 9646006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.
    Olkkola KT; Brunetto AV; Mattila MJ
    Clin Pharmacokinet; 1994 Feb; 26(2):107-20. PubMed ID: 8162655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlortenoxicam pharmacokinetics in young and elderly human volunteers.
    Ankier SI; Brimelow AE; Crome P; Johnston A; Warrington SJ; Turner P; Ferber HP
    Postgrad Med J; 1988 Oct; 64(756):752-4. PubMed ID: 3255915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of piroxicam: new aspects.
    Fenner H
    Eur J Rheumatol Inflamm; 1987; 8(1):42-8. PubMed ID: 3622592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the CYP2C9*3 allele on lornoxicam metabolism.
    Liu YL; Zhang W; Tan ZR; Ouyang DS; Luo CH; Liu ZQ; Qiu Y; Chen Y; He YJ; Zhou G; Zhou HH
    Clin Chim Acta; 2006 Feb; 364(1-2):287-91. PubMed ID: 16182270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal and gastrointestinal tolerability of lornoxicam, and effects on haemostasis and hepatic microsomal oxidation.
    Warrington SJ; Lewis Y; Dawnay A; Johnston A; Kovacs IB; Lamb E; Ravic M
    Postgrad Med J; 1990; 66 Suppl 4():S35-40. PubMed ID: 2284219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of lornoxicam in human plasma by LC/MS/MS].
    Zeng YL; Chen XY; Zhang YF; Zhong DF
    Yao Xue Xue Bao; 2004 Feb; 39(2):132-5. PubMed ID: 15127622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption of oral lornoxicam in healthy volunteers using a granular formulation in comparison with standard tablets.
    Bareggi SR; Gambaro V; Valenti M; Benvenuti C
    Arzneimittelforschung; 1997 Jun; 47(6):755-7. PubMed ID: 9239455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of the pharmacological properties, pharmacokinetics and animal safety assessment of lornoxicam.
    Pruss TP; Stroissnig H; Radhofer-Welte S; Wendtlandt W; Mehdi N; Takacs F; Fellier H
    Postgrad Med J; 1990; 66 Suppl 4():S18-21. PubMed ID: 2284216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lornoxicam in clinical practice.
    Berry H; Ollier S
    Postgrad Med J; 1990; 66 Suppl 4():S41-5. PubMed ID: 2284220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacological studies of some possible interactions of lornoxicam with other drugs.
    Ravic M; Johnston A; Turner P
    Postgrad Med J; 1990; 66 Suppl 4():S30-4. PubMed ID: 2126624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacokinetic interaction between cimetidine or ranitidine and lornoxicam.
    Ravic M; Salas-Herrera I; Johnston A; Turner P; Foley K; Rosenow DE
    Postgrad Med J; 1993 Nov; 69(817):865-6. PubMed ID: 8290432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of concomitantly administered antacids on the bioavailability of lornoxicam, a novel highly potent NSAID.
    Dittrich P; Radhofer-Welte S; Magometschnigg D; Kukovetz WR; Mayerhofer S; Ferber HP
    Drugs Exp Clin Res; 1990; 16(2):57-62. PubMed ID: 2401187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of pharmacokinetic drug/drug interactions from In vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants.
    Kohl C; Steinkellner M
    Drug Metab Dispos; 2000 Feb; 28(2):161-8. PubMed ID: 10640513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative population pharmacokinetic-pharmacodynamic analysis for piroxicam-beta-cyclodextrin and piroxicam.
    Wang D; Miller R; Zheng J; Hu C
    J Clin Pharmacol; 2000 Nov; 40(11):1257-66. PubMed ID: 11075311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lornoxicam efficacy in acute pain (LEAP) trial.
    Sharma A; Pingle A; Baliga VP
    J Indian Med Assoc; 2008 Dec; 106(12):811-3. PubMed ID: 19370957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of cholestyramine on the elimination of tenoxicam and piroxicam.
    Guentert TW; Defoin R; Mosberg H
    Eur J Clin Pharmacol; 1988; 34(3):283-9. PubMed ID: 3260866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lornoxicam attenuates the haemodynamic responses to laryngoscopy and tracheal intubation in the elderly.
    Riad W; Moussa A
    Eur J Anaesthesiol; 2008 Sep; 25(9):732-6. PubMed ID: 18471327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.